Wild trading (@YYDSxjm) header
Wild trading (@YYDSxjm) profile picture

Bull Market Lover šŸ‚šŸ‚

YYDS
Joined August 2024
Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)Photo by Wild trading (@YYDSxjm)
$SMCI former big 4 auditor here. I can tell you the 10k will be filed either late Monday or on Tuesday. Main reason being is BDO was hired on short notice and they will take all the time they can get to ensure everything is buttoned up. They can’t risk issuing a report ā€œearlyā€ and having something come back to bite them and then having to answer about why they didn’t take the time they needed. Also, these reports have to go to the audit committee for sign off so there’s a process it goes through before getting filed. Its coming, just know you’re going to have to be fine with it coming at the deadline
23
15
5
205
54,980
Wild trading retweeted
$ASTS Where is the damn bottom for this thing? It’s like being in hell and then realizing there’s another hell further down for people who aren’t quite good enough to be in regular hell. Abel and management need to get it together.
6
2
25
2,260
Wild trading retweeted
$NWBO This whole situation is crazy. Literally, every attempt by the Big pharma, trying to circumvent DCVAX technology has failed. All of them. Trial by trial, Merck, Bristol Mayers, Moderna, Pfizer, Gilliad, etc. The efforts to control the stock price movement are obvious. The question is, how many FTDs, failed to deliver, synthetic , short shares are out there that will need to be repurchased? The estimated numbers vary from few hundred millions to a few billion. The potential for a violent price movement in a short squeeze scenario is staggering. That’s why the price suppression to the lowest possible band is taking place to frustrate the holders and to make them sell cheap once the announcements arrive. This will do very well on its own, but the short term squeeze potential of the likes of GME, GameStop, is real. This will be very rewarding to the steady hands.
2
14
101
1,751
Wild trading retweeted
$VKTX The whole "BL wants $xxxxxB" posts are tiresome. No one knows what BL wants - if anything. We know only what he has stated. At this point, he is willing to sell/lease non-VK2735 assets, but wants to commericalize VK2735 (and probably VK3019) in-house. Whether the "house" gets bought - or is even for sale - is another matter. All these posts presuming to know his demands are fevered dreams. What we do know, OTOH, is that the future value of a Viking selling VK2735 SQ/PO doses absolutely dwarves its present value by as much as two orders of magnitude 5-7 years from now. BL knows this. Why sell for pennies today what will be worth dollars in short order? He has built this company from scratch over 13 years ago. Why on earth would he let it go before it reaches its full potential? Long hold. Insanely...
2
1
23
1,391
$ASTS Guys, in the end, even if it takes time, AST is inevitable. Starlink has proven through its integration strategy and business policy that it intends to compete with MNOs. It’s unrealistic to think that Starlink will capture a major share of the market, because an integrated model means that a significant portion of depreciation costs is factored into the selling price. Even if AST arrives later, our model is inevitable as a complementary service to a user’s traditional mobile plan, at a reasonable cost that’s accessible to the majority of the population.
5
1
1
68
3,232
$TTWO They’re in a tough spot right now. No bugs, no spoilers, glowing reviews. How are they gonna justify the Take-Two stock drop like we expected šŸ¤” Oh well, who cares, doesn’t need an explanation. It’ll end in the red, you'll see…
1
1
208
$VKTX The whole "BL wants $xxxxxB" posts are tiresome. No one knows what BL wants - if anything. We know only what he has stated. At this point, he is willing to sell/lease non-VK2735 assets, but wants to commericalize VK2735 (and probably VK3019) in-house. Whether the "house" gets bought - or is even for sale - is another matter. All these posts presuming to know his demands are fevered dreams. What we do know, OTOH, is that the future value of a Viking selling VK2735 SQ/PO doses absolutely dwarves its present value by as much as two orders of magnitude 5-7 years from now. BL knows this. Why sell for pennies today what will be worth dollars in short order? He has built this company from scratch over 13 years ago. Why on earth would he let it go before it reaches its full potential? Long hold. Insanely...
2
1
23
1,391
$NWBO This whole situation is crazy. Literally, every attempt by the Big pharma, trying to circumvent DCVAX technology has failed. All of them. Trial by trial, Merck, Bristol Mayers, Moderna, Pfizer, Gilliad, etc. The efforts to control the stock price movement are obvious. The question is, how many FTDs, failed to deliver, synthetic , short shares are out there that will need to be repurchased? The estimated numbers vary from few hundred millions to a few billion. The potential for a violent price movement in a short squeeze scenario is staggering. That’s why the price suppression to the lowest possible band is taking place to frustrate the holders and to make them sell cheap once the announcements arrive. This will do very well on its own, but the short term squeeze potential of the likes of GME, GameStop, is real. This will be very rewarding to the steady hands.
2
14
101
1,751
$NWBO BYW, Richard is NWBO’s new Manager of Investor Relations!
3
2
42
1,581
$ASTS Where is the damn bottom for this thing? It’s like being in hell and then realizing there’s another hell further down for people who aren’t quite good enough to be in regular hell. Abel and management need to get it together.
6
2
25
2,260
Wild trading retweeted
$ASTS Keep selling your stock to make others rich. Elequin Capital LP grew its position in AST SpaceMobile by 354.8% during the 3rd quarter. Entropy Technologies LP bought a new stake in shares of AST SpaceMobile in the 3rd quarter worth $7,166,000. Jump Financial LLC purchased a new position in shares of AST SpaceMobile in the third quarter worth $835,000. Pathstone Holdings LLC raised its stake in shares of AST SpaceMobile by 3.3% in the third quarter. Headlands Technologies LLC lifted its holdings in shares of AST SpaceMobile by 132.8% during the third quarter. 60.95% of the stock is owned by institutional investors. Don't let bears and shorts change your investment thesis. There might be some delays, but major contracts keep coming in. If prices go lower, i'll be adding more.
5
5
1
61
3,282
$IBRX Watch out for hedgies leaping out of skyscrapers over SLS today. Short interest 57 million short. Margin call due tomorrow a cool 700 million. I love it because the hedgies short this are short IBRX like other bios. Same story for IBRX one morning. Thanks hedgies for my gains in SLS. Dr. Pat is gonna get you snakes next.
19
978
$ASTS Keep selling your stock to make others rich. Elequin Capital LP grew its position in AST SpaceMobile by 354.8% during the 3rd quarter. Entropy Technologies LP bought a new stake in shares of AST SpaceMobile in the 3rd quarter worth $7,166,000. Jump Financial LLC purchased a new position in shares of AST SpaceMobile in the third quarter worth $835,000. Pathstone Holdings LLC raised its stake in shares of AST SpaceMobile by 3.3% in the third quarter. Headlands Technologies LLC lifted its holdings in shares of AST SpaceMobile by 132.8% during the third quarter. 60.95% of the stock is owned by institutional investors. Don't let bears and shorts change your investment thesis. There might be some delays, but major contracts keep coming in. If prices go lower, i'll be adding more.
5
5
1
61
3,282
Wild trading retweeted
$ONDS After this weekend's 60 Minutes' expose on Iran's drone strikes on a US/Kuwaiti base you'd think people would realize the stakes in this game, and why ONDS is an important (vital!) part of our counter-drone defense. Basically, we currently have no counter-drone capability, as evidenced by the 60 MInutes expose.
1
1
19
2,570
Wild trading retweeted
$IBRX missed sales expectations by about $10 m and the quarter slowed about $2 M but the TAM tripled from about $50 M to $150 M. Last three quarters increased by 91%. Sales growth actually is strong if you look at the last 3 quarters and the prospects for the next 3 quarters which seems to be about $400M to $500M instead of $145 M. That is a great amount of growth being ignored. Our top line results for BCG Naive were extremely successful, and the only thing we don't know yet is how successful. IBRX is on track for an sBLA filing, which if successful next year, should raise quarterly sales to about $500 for the BC program. If I am right, that will be a blockbuster drug hitting the $2B in annual sales rate going forward -- some time in $2027. I A rapidly growning $2B sales company would at least be capable of a 10x sales multiple or $20 B, roughly 3x the current price. Thus the full BC franchise alone is worth about $18/sh probably much more when the shorts are forced to cover.
3
1
1
48
1,913
Wild trading retweeted
Just now: Trump administration to press ahead and block imports of AI DC equipment from China, such as new optical transceiver models. Despite opposition from hyperscalers like $AMZN to solana:GooGLMvZtJZXHdNZy95RUrAMCCKxV6ghK3qE5ddBgVm5 This move benefits Western optical transceiver and laser + component supply chains. While negatively impacting players like Innolight, Eoptolink, and upstream Chinese suppliers. China hawks in Washington were concerned Chinese transceivers could be used by Beijing to steal data, install malware, or disrupt ​US DC services.
215
112
69
1,447
453,958
$SMCI same stock price as 2023 Revenue 2023: 7 billion Revenue 2026: 40 billion
1
365
$IBRX missed sales expectations by about $10 m and the quarter slowed about $2 M but the TAM tripled from about $50 M to $150 M. Last three quarters increased by 91%. Sales growth actually is strong if you look at the last 3 quarters and the prospects for the next 3 quarters which seems to be about $400M to $500M instead of $145 M. That is a great amount of growth being ignored. Our top line results for BCG Naive were extremely successful, and the only thing we don't know yet is how successful. IBRX is on track for an sBLA filing, which if successful next year, should raise quarterly sales to about $500 for the BC program. If I am right, that will be a blockbuster drug hitting the $2B in annual sales rate going forward -- some time in $2027. I A rapidly growning $2B sales company would at least be capable of a 10x sales multiple or $20 B, roughly 3x the current price. Thus the full BC franchise alone is worth about $18/sh probably much more when the shorts are forced to cover.
3
1
1
48
1,913
$KEEL This so called "valuation reset" argument sweeping across the tech sector [ROI does not justify the forward multiples] has become irrational. The choice is clear. You can either knuckle under and panic sell or bite the bullet and stay the course. I hate being bluffed out of a pot. Pressure makes diamonds.
8
809
$ONDS After this weekend's 60 Minutes' expose on Iran's drone strikes on a US/Kuwaiti base you'd think people would realize the stakes in this game, and why ONDS is an important (vital!) part of our counter-drone defense. Basically, we currently have no counter-drone capability, as evidenced by the 60 MInutes expose.
1
1
19
2,570
$NWBO most of the people commenting here are incompetent, own no shares and trying to make a penny. Ignore it all and buy. Do not sell.
1
24
944